Abstract: The C-terminal 232-419 amino acids fragment of endonuclease Sau3AI has been successfully expressed in Escherichia coli with 6 His at its N-terminal. After purification and crystallization, one completed 2.8 Å data set was collected using a Rigaku R-AXIS IV ++ diffractometer. The plate-like crystals belong to orthorhombic space group P2 1 2 1 2 1 with the cell dimension of a = 34.75, b = 76.82, c = 123.59Å and contain one molecule per asymmetric unit.
INTRODUCTION
The type II restriction endonuclease Sau3AI is widely used in generating gene libraries and in genome research. It was first isolated from group II Staphylococcus aureus 3AI [1] and is also expressed in Staphylococcus carnosus TM300 [2] . Sau3AI recognizes the sequence 5'-GATC-3' and cleaves 5' to G residue on each strand regardless of whether the A residue is unmethylated, hemimethylated or fully methylated. In a bacterial restriction-modification system, one specific DNA methyltransferase (also called Sau3AI methyltransferase) can methylate the C residue to protect host DNA from Sau3AI cleavage.
The N-terminal domain of Sau3AI displays high sequence similarity with Escherichia coli mismatch repair endonuclease MutH [3] . Beside the same GATC recognition sequence, they have the same catalytic sequence motif D(X) (E/D)XK as in many other type II restriction enzymes [4, 5] . Unlike Sau3AI, MutH can only cleave unmethylated daughter strand in hemimethylated DNA. The endonuclease activity of MutH is also dependent on MutL and MutS protein [6, 7, 8] .
The role of C-terminal fragment of Sau3AI in DNA binding and cleavage specificity is still unclear. We expressed the C-terminal Sau3AI fragment in E. coli to investigate its structure and function. In this paper we report the preliminary X-ray results of C-terminal Sau3AI crystals.
MATERIALS AND METHODS

Expression and Purification
Plasmid pWY1440 containing full length Sau3AI gene from Staphylococcus aureus 3AI in pET15b was a gift from Dr. Wei Yang (NIDDK/NIH, USA). It has an E64A / GAA→GCA potential active site mutation and silence mu- tations at the C terminal end: from 1444 -aaa aag caa gtt gaa gat -1461 to 1444 -aag aag caa gtg gag gac-1461. A plasmid containing C terminal 232-419aa fragment of Sau3AI in pET15b with NdeI-BamHI sites was constructed based on plasmid pWY1440. C-terminal Sau3AI fragment of 232-419 amino acids, with 6 His and a thrombin digestion site and a mutation of original 232 leucine to methionine (ATA→ATG) at the N-terminal, was expressed in E. coli Rossetta plysS cells at 25°C after 8hr with 0.2mM IPTG induction.
Frozen cell paste were resuspended in 20mM Tris-HCl pH8.0 / 300mM NaCl / 1.4mM 2-mercaptoethanol and lysed by sonication for 60s, 3 times at 4°C. 1mM PMSF were added to inhibit protease. After centrifuging at 16,000rpm for 30 min, the supernatant was loaded on Ni-NTA and eluted from Ni Column by using a buffer containing 20mM Tris-HCl pH8.0 / 300mM NaCl /1.4mM 2-mercaptoethanol / 300mM imidazole. The sample was diluted using 2 times volume of 20mM Tris-HCl pH8.0 / 1mM DTT / 5% glycerol and loaded on an Amersham HiTrap Q HP column. Then the C-terminal Sau3AI protein was eluted out during a gradient to 20mM Tris-HCl pH8.0 / 1mM DTT / 400mM KCl / 5% Glycerol. Finally pure C-terminal Sau3AI protein was concentrated in the buffer of 20mM HEPES pH7.2 / 200mM KCl / 5mM MgCl 2 / 1mM EDAT / 1mM DTT / 5% glycerol using Millipore Amicon Ultra 10KD. Fresh protein was concentrated to over 20mg/ml and was diluted to 8mg/ml for crystallization.
Crystallization and X-Ray Data Collection
Crystallization was carried out by the hanging drop vapor diffusion method in 4°C. 1µl of 8mg/ml protein was mixed with 1 µl reservoir solution of 10% -12% tert-butanol / 0.1 M MES pH 5.7 -6.7. Plate-like crystals appeared after 12 hr and finally grew to about 0.5 x 0.4 x 0.02 mm (Fig. 1) . Crystals were gradually transferred to the cryo-solution 20% tert-Butanol / 20% glycerol / 0.1 M MES pH 6.3 / 100 mM KCl / 5mM MgCl 2 / 1 mM EDTA / 1 mM DTT. X-ray diffraction data was collected using a home source Rigaku R-AXIS IV ++ diffractometer with 5 min exposure time for each image. One completed data set was obtained by collecting 180 images with 1º oscillation. CrystalClear [10] was used for data indexing and integration. 
RESULTS AND DISCUSSION
The preliminary crystallography results of C-terminal half of Sau3AI are shown in Table 1 . The N-terminal half of Sau3AI is more likely to contain the restriction enzyme active domain according to the sequence alignment and potential active sites mutation experiments (unpublished data). However, the C-terminal of Sau3AI shows some sequence similarity with the N-terminal half and it has been suggested that Sau3AI is in fact a pseudodimer [9] . If so, then the Cterminal Sau3AI may also contain a DNA binding site and be an allosteric effector domain [11] as in the EcoRII [12, 13] and Nael [14, 15] . Solving the structure of the C-terminal half of Sau3AI will illustrate its role in protein function and character. 
